Tyme Technologies, Inc. to Present at the Rodman & Renshaw 20th Annual Global Investment Conference
NEW YORK, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ:TYME), a clinical-stage oncology company developing metabolically-based cancer therapeutics, today announced that it will be featured as a presenting company at the Rodman & …